Both markers are moderately correlated (Spearman r = 0.5, p = 0.01), suggesting that IL-33 and ST2 variants present in the tumor are related to fibroblast activation and could potentiate the desmoplastic reaction of the tumor. The gene discussed is IL33; the disease is neoplasm.